SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001104659-24-082668 from MUSTANG BIO, INC. (MBIO) (CIK 0001680048) (MBIO)

MUSTANG BIO, INC. (MBIO) (CIK 0001680048)
Date: July 25, 2024 · CIK: 0001680048 · Accession: 0001104659-24-082668

AI Filing Summary & Sentiment

File numbers found in text: 333-280927

Date
July 25, 2024
Author
Not clearly detected
Form
CORRESP
Company
MUSTANG BIO, INC. (MBIO) (CIK 0001680048)

Letter

Mustang Bio, Inc.

377 Plantation Street

Worcester, Massachusetts 01605

VIA EDGAR

July 25, 2024

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Lauren S. Hamill

Re: Mustang Bio, Inc.

Registration Statement on Form S-1 (Reg. No. 333-280927)

Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Mustang Bio, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 5:00 p.m. Eastern time, on July 29, 2024, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or Alexander Yarbrough, both of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Hamilton Sanders LLP, to orally modify or withdraw this request for acceleration.

Once the Registration Statement has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Yarbrough at (704) 998-4077.

Thank you for your assistance in this matter.

Very truly yours,
Mustang Bio, Inc.

Show Raw Text
CORRESP
1
filename1.htm

Mustang Bio, Inc.

377 Plantation Street

Worcester, Massachusetts 01605

VIA EDGAR

July 25, 2024

Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, D.C. 20549

Attn: Lauren S. Hamill

    Re:
    Mustang Bio, Inc.

    Registration Statement on Form S-1 (Reg. No. 333-280927)

    Request for Acceleration of Effective Date

Ladies and Gentlemen:

Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Mustang Bio, Inc. (the “Company”) hereby requests that the Securities and Exchange
Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form
S-1 (the “Registration Statement”) so that the Registration Statement will be declared effective as of 5:00 p.m. Eastern
time, on July 29, 2024, or as soon as practicable thereafter. The Company hereby authorizes Rakesh Gopalan or Alexander Yarbrough, both
of whom are attorneys at the Company’s outside legal counsel, Troutman Pepper Hamilton Sanders LLP, to orally modify or withdraw
this request for acceleration.

Once the Registration Statement
has been declared effective, please orally confirm that event with Mr. Gopalan at (704) 916-2374 or Mr. Yarbrough at (704) 998-4077.

Thank you for your assistance
in this matter.

    Very truly yours,

    Mustang Bio, Inc.

    /s/ Manuel Litchman

    Name:
    Manuel Litchman, M.D.

    Title:
    President, Chief Executive Officer and Director

    cc (via email):
    Rakesh Gopalan and Alexander Yarbrough, Troutman Pepper Hamilton Sanders LLP